Category: 22013-33-8

22013-33-8, In an article, published in an article,authors is Chapleo, Christopher B., once mentioned the application of 22013-33-8, Name is 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine,molecular formula is C8H9NO2, is a conventional compound. this article was the specific content is as follows.

Effect of 1,4-dioxanyl substitution on the adrenergic activity of some standard alpha-adrenoreceptor agents

A preliminary communication reported on the pharmacology of the potent partial alpha2-agonist (2-(1,4-benzodioxan-6-ylamino)-2-imidazoline, a 1,4-dioxan derivative of clonidine.Its degree of agonism/antagonism depended upon the peripheral or central alpha2-adrenoreceptor system studied.It was of interest to discover whether a similar substitution of the 1,4-dioxan moiety in other standard alpha-adrenergic agents would similary produce high affinity compounds of complex pharmacological profile.The same substitution when introduced into guanfacine, fenmetazole and tolazoline resulted in unpredictable changes in profile with a reduction in alpha-affinity. – alpha2-adrenoreceptors/antagonism/agonism/clonidine derivatives/1,4-dioxan derivatives

22013-33-8, Interested yet? Read on for other articles about 22013-33-8!

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

22013-33-8, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 22013-33-8, molecular formula is C8H9NO2, introducing its new discovery.

NOVEL INHIBITORS OF PROTEIN KINASE C EPSILON SIGNALING

The present invention relates to novel inhibitors of protein kinase C epsilon (PKCepsilon) signaling, including in particular the compounds of formula (I) as described and defined herein, pharmaceutical compositions comprising these inhibitors, and their use in the treatment or prevention of disorders such as, e.g., a cardiovascular disorder, cardiac hypertrophy, heart failure, anxiety, pain, chronic pain, migraine, an allergy, an inflammatory disorder, an autoimmune disorder, diabetes, diabetic complications, diabetic retinopathy, diabetic nephropathy, diabetic cardiomyopathy, diabetic neuropathy, cancer, metastatic cancer, drug-resistant cancer, stomach cancer, lung cancer, thyroid cancer, colon cancer, breast cancer, a neurological disorder, Alzheimer’s disease, Parkinson’s disease, bipolar disorder, stroke, alopecia, or alcoholism.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.22013-33-8, you can also check out more blogs about22013-33-8

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

22013-33-8, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.22013-33-8, Name is 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine, molecular formula is C8H9NO2. In a Article, authors is Shi, Yang£¬once mentioned of 22013-33-8

General rhodium-catalyzed oxidative cross-coupling reactions between anilines: Synthesis of unsymmetrical 2,2?-diaminobiaryls

Described herein is a dual chelation-assisted RhCl3-catalyzed oxidative C-H/C-H cross-coupling reaction of aniline derivatives. The highlight of this methodology is the chemo- and regioselective cross-coupling between electronically similar substrates, which represents a highly challenging task in oxidative Ar-H/Ar-H cross-coupling reactions. Furthermore, this Cp?-free catalytic reaction tolerates a range of functional groups and requires only a low molar ratio of coupling partners. These features expedite the synthesis of unsymmetrical 2,2?-diaminobiaryls.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.22013-33-8. In my other articles, you can also check out more blogs about 22013-33-8

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

22013-33-8, Chemistry can be defined as the study of matter and the changes it undergoes. You¡¯ll sometimes hear it called the central science because it is the connection between physics and all the other sciences, starting with biology.22013-33-8, Name is 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine, molecular formula is C8H9NO2, introducing its new discovery.

Ruthenium-Catalyzed Site-Selective Trifluoromethylations and (Per)Fluoroalkylations of Anilines and Indoles

Introducing (per)fluoroalkyl groups into arenes continues to be an interesting, but challenging area in organofluorine chemistry. We herein report an ortho-selective C?H perfluoroalkylation including trifluoromethylations of anilines and indoles without the need of protecting groups using RfI and RfBr as commercially available reagents. The availability and price of the starting materials and the inherent selectivity make this novel methodology attractive for the synthesis of diverse (per)fluoroalkylated building blocks, for example, for bioactive compounds and materials.

22013-33-8, Interested yet? Read on for other articles about 22013-33-8!

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

22013-33-8, Chemistry is the experimental and theoretical study of materials on their properties at both the macroscopic and microscopic levels.In a patent£¬Which mentioned a new discovery about 22013-33-8

LIGANDS TO CEREBLON (CRBN)

Disclosed are compounds with immunomodulatory activity, methods of making the compounds, pharmaceutical compositions containing the compounds, and methods of using the compounds to treat diseases or disorders characterized or mediated by dysfunctional protein activity.

22013-33-8, Interested yet? Read on for other articles about 22013-33-8!

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

An article , which mentions 22013-33-8, molecular formula is C8H9NO2. The compound – 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine played an important role in people’s production and life., 22013-33-8

Structural studies and characterization of 3-formylchromone and products of its reactions with chosen primary aromatic amines

The crystal structure and FTIR spectrum of 3-formylchromone (0) have been analysed. A new organic ligands, 3-(anilinomethylene)-2-methoxychroman-4-one (1) and 3-(1?,4?-benzodioxan-6?-aminomethylene)-2-methoxychroman- 4-one (2) were synthesized. The products of reactions between 3-formylchromone and aniline and 6-amino-1,4,-benzodioxane were studied by elemental analysis, FTIR spectroscopy, thermal analysis and X-ray crystallography. It has been found that these reactions allow to obtain derivatives of 4-chromanones from 3-formylchromone by the mechanism of nucleophilic addition, accompanied by the opening of the pyrone ring. The experimental results indicate that compounds (1) and (2) are thermal stable up to 90 and 100 C, respectively. The FTIR spectra and X-ray analysis showed the present of methoxy-group in these compounds.

But sometimes, even after several years of basic chemistry education, it is not easy to form a clear picture on how they govern reactivity! Read on for other articles about 23687-27-6!, 22013-33-8

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.22013-33-8, Name is 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine, molecular formula is C8H9NO2, 22013-33-8. In a Article, authors is Sun, Zhuming£¬once mentioned of 22013-33-8

Synthesis, in vitro evaluation and cocrystal structure of 4-oxo-[1]benzopyrano[4,3-c]pyrazole cryptosporidium parvum inosine 5?-monophosphate dehydrogenase (Cp IMPDH) inhibitors

Cryptosporidium inosine 5?-monophosphate dehydrogenase (CpIMPDH) has emerged as a therapeutic target for treating Cryptosporidium parasites because it catalyzes a critical step in guanine nucleotide biosynthesis. A 4-oxo-[1]benzopyrano[4,3-c]pyrazole derivative was identified as a moderately potent (IC50 = 1.5 muM) inhibitor of CpIMPDH. We report a SAR study for this compound series resulting in 8k (IC50 = 20 ¡À 4 nM). In addition, an X-ray crystal structure of CpIMPDH¡¤IMP¡¤8k is also presented.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.22013-33-8. In my other articles, you can also check out more blogs about 22013-33-8

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

22013-33-8, In an article, published in an article,authors is Calil, Felipe A., once mentioned the application of 22013-33-8, Name is 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine,molecular formula is C8H9NO2, is a conventional compound. this article was the specific content is as follows.

Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase

Schistosomiasis ranks second only to malaria as the most common parasitic disease worldwide. 700 million people are at risk and 240 million are already infected. Praziquantel is the anthelmintic of choice but decreasing efficacy has already been documented. In this work, we exploited the inhibition of Schistosoma mansoni dihydroorotate dehydrogenase (SmDHODH) as a strategy to develop new therapeutics to fight schistosomiasis. A series of quinones (atovaquone derivatives and precursors) was evaluated regarding potency and selectivity against both SmDHODH and human DHODH. The best compound identified is 17 (2-hydroxy-3-isopentylnaphthalene-1,4-dione) with IC50 = 23 ¡À 4 nM and selectivity index of 30.83. Some of the new compounds are useful pharmacological tools and represent new lead structures for further optimization.

If you are interested in 22013-33-8, you can contact me at any time and look forward to more communication. 22013-33-8

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

22013-33-8, Chemistry is traditionally divided into organic and inorganic chemistry. The former is the study of compounds containing at least one carbon-hydrogen bonds.In a patent£¬Which mentioned a new discovery about 22013-33-8

Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same

The present invention relates to novel quinoline derivatives and quinazoline derivatives represented by the following formula (I): STR1 [wherein R 1 and R 2 are each independently H or C 1 -C 4 -alkyl, or R 1 and R 2 together form C 1 -C 3 -alkylene, X is O, S or CH 2, W is CH or N, and Q is a substituted aryl group or substituted heteroaryl group] and their pharmaceutically acceptable salts, having platelet-derived growth factor receptor autophosphorylation inhibitory activity, to pharmaceutical compositions containing these compounds, and to methods for the treatment of diseases associated with abnormal cell growth such as tumors.

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, 22013-33-8, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 22013-33-8

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem

22013-33-8, One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, such as the rate of change in the concentration of reactants or products with time.In a article, authors is Mahal, Katharina, mentioned the application of 22013-33-8, Name is 2,3-Dihydrobenzo[b][1,4]dioxin-6-amine, molecular formula is C8H9NO2

Effects of the tumor-vasculature-disrupting agent verubulin and two heteroaryl analogues on cancer cells, endothelial cells, and blood vessels

Two analogues of the discontinued tumor vascular-disrupting agent verubulin (Azixa, MPC-6827, 1) featuring benzo-1,4-dioxan-6-yl (compound 5 a) and N-methylindol-5-yl (compound 10) residues instead of the para-anisyl group on the 4-(methylamino)-2-methylquinazoline pharmacophore, were prepared and found to exceed the antitumor efficacy of the lead compound. They were antiproliferative with single-digit nanomolar IC50 values against a panel of nine tumor cell lines, while not affecting nonmalignant fibroblasts. Indole 10 surpassed verubulin in seven tumor cell lines including colon, breast, ovarian, and germ cell cancer cell lines. In line with docking studies indicating that compound 10 may bind the colchicine binding site of tubulin more tightly (Ebind=-9.8 kcal mol-1) than verubulin (E bind=-8.3 kcal mol-1), 10 suppressed the formation of vessel-like tubes in endothelial cells and destroyed the blood vessels in the chorioallantoic membrane of fertilized chicken eggs at nanomolar concentrations. When applied to nude mice bearing a highly vascularized 1411HP germ cell xenograft tumor, compound 10 displayed pronounced vascular-disrupting effects that led to hemorrhages and extensive central necrosis in the tumor. Variations on a promising theme: Tumor blood vessels are a good therapeutic target because they are fundamentally different from normal vasculature. This study shows that vascular-disrupting agents derived from verubulin have enhanced selectivity for cancer cells and lower general in vivo toxicity, yet they retain the strong antivascular activity of the lead compound.

22013-33-8, Interested yet? Read on for other articles about 22013-33-8!

Reference£º
Benzodioxan,
1,4-Benzodioxane | C8H8O2 – PubChem